vWF and Propeptide Levels in Healthy Individuals After Stimulation of the Endothelium by Endotoxin, DDAVP, and Exercise
Perturbant . | vWF (mature) (nmol/L ± SEM) . | Propeptide (nmol/L ± SEM) . | No. of Subjects . |
---|---|---|---|
LPS | |||
0 h | 29.4 ± 4.7 | 4.2 ± 0.9 | 8 |
3 h | 144.3 ± 11.71-153 | 55.2 ± 4.61-153 | |
24 h | 88.7 ± 10.01-153 | 6.0 ± 0.5 (NS) | |
DDAVP | |||
0 h | 40.5 ± 7.0 | 6.1 ± 0.3 | 9 |
1 h | 104.8 ± 13.81-153 | 46.2 ± 4.71-153 | |
6 h | 81.0 ± 16.0† | 14.8 ± 3.1† | |
Exercise | |||
0 h | 40.4 ± 3.9 | 7.1 ± 0.8 | 5 |
5 min* | 112.6 ± 17.9‡ | 40.7 ± 11.7‡ |
Perturbant . | vWF (mature) (nmol/L ± SEM) . | Propeptide (nmol/L ± SEM) . | No. of Subjects . |
---|---|---|---|
LPS | |||
0 h | 29.4 ± 4.7 | 4.2 ± 0.9 | 8 |
3 h | 144.3 ± 11.71-153 | 55.2 ± 4.61-153 | |
24 h | 88.7 ± 10.01-153 | 6.0 ± 0.5 (NS) | |
DDAVP | |||
0 h | 40.5 ± 7.0 | 6.1 ± 0.3 | 9 |
1 h | 104.8 ± 13.81-153 | 46.2 ± 4.71-153 | |
6 h | 81.0 ± 16.0† | 14.8 ± 3.1† | |
Exercise | |||
0 h | 40.4 ± 3.9 | 7.1 ± 0.8 | 5 |
5 min* | 112.6 ± 17.9‡ | 40.7 ± 11.7‡ |